AGL 39.18 Decreased By ▼ -0.82 (-2.05%)
AIRLINK 127.95 Decreased By ▼ -1.11 (-0.86%)
BOP 6.85 Increased By ▲ 0.10 (1.48%)
CNERGY 4.70 Increased By ▲ 0.21 (4.68%)
DCL 8.41 Decreased By ▼ -0.14 (-1.64%)
DFML 41.20 Increased By ▲ 0.38 (0.93%)
DGKC 82.20 Increased By ▲ 1.24 (1.53%)
FCCL 33.11 Increased By ▲ 0.34 (1.04%)
FFBL 74.20 Decreased By ▼ -0.23 (-0.31%)
FFL 11.83 Increased By ▲ 0.09 (0.77%)
HUBC 110.10 Increased By ▲ 0.52 (0.47%)
HUMNL 14.10 Increased By ▲ 0.35 (2.55%)
KEL 5.23 Decreased By ▼ -0.08 (-1.51%)
KOSM 7.58 Decreased By ▼ -0.14 (-1.81%)
MLCF 39.25 Increased By ▲ 0.65 (1.68%)
NBP 63.68 Increased By ▲ 0.17 (0.27%)
OGDC 192.95 Decreased By ▼ -1.74 (-0.89%)
PAEL 25.55 Decreased By ▼ -0.16 (-0.62%)
PIBTL 7.28 Decreased By ▼ -0.11 (-1.49%)
PPL 153.40 Decreased By ▼ -2.05 (-1.32%)
PRL 25.55 Decreased By ▼ -0.24 (-0.93%)
PTC 17.53 Increased By ▲ 0.03 (0.17%)
SEARL 81.70 Increased By ▲ 3.05 (3.88%)
TELE 7.67 Decreased By ▼ -0.19 (-2.42%)
TOMCL 33.49 Decreased By ▼ -0.24 (-0.71%)
TPLP 8.43 Increased By ▲ 0.03 (0.36%)
TREET 16.30 Increased By ▲ 0.03 (0.18%)
TRG 56.60 Decreased By ▼ -1.62 (-2.78%)
UNITY 27.58 Increased By ▲ 0.09 (0.33%)
WTL 1.35 Decreased By ▼ -0.04 (-2.88%)
BR100 10,501 Increased By 55.8 (0.53%)
BR30 31,116 Decreased By -73.5 (-0.24%)
KSE100 98,203 Increased By 405.1 (0.41%)
KSE30 30,666 Increased By 185 (0.61%)
World

AstraZeneca says it will work with Dutch over vaccine queries

  • "Regulatory authorities in the UK, European Union, the World Health Organization have concluded that the benefits of using our vaccine to protect people from this deadly virus significantly outweigh the risks across all adult age groups," a spokesman for AstraZeneca said in a statement.
Published April 2, 2021

LONDON: AstraZeneca said on Friday it was working with Dutch authorities to address any questions they had after the Netherlands temporarily suspended use of its COVID-19 vaccine for people under 60 following the death of a woman who had received a shot.

"Regulatory authorities in the UK, European Union, the World Health Organization have concluded that the benefits of using our vaccine to protect people from this deadly virus significantly outweigh the risks across all adult age groups," a spokesman for AstraZeneca said in a statement.

"Tens of millions of people have now received our vaccine across the globe. The extensive body of data from two large clinical datasets and real-world evidence demonstrate its effectiveness, reaffirming the role the vaccine can play during this public health crisis."

Comments

Comments are closed.